Cargando…

Effects of intramuscularly administered enrofloxacin on the susceptibility of commensal intestinal Escherichia coli in pigs (sus scrofa domestica)

BACKGROUND: In the European Union, various fluoroquinolones are authorised for the treatment of food producing animals. Each administration poses an increased risk of development and spread of antimicrobial resistance. The aim of this study was to investigate the impact of parenteral administration...

Descripción completa

Detalles Bibliográficos
Autores principales: Römer, Antje, Scherz, Gesine, Reupke, Saskia, Meißner, Jessica, Wallmann, Jürgen, Kietzmann, Manfred, Kaspar, Heike
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5715528/
https://www.ncbi.nlm.nih.gov/pubmed/29202759
http://dx.doi.org/10.1186/s12917-017-1260-8
_version_ 1783283782657245184
author Römer, Antje
Scherz, Gesine
Reupke, Saskia
Meißner, Jessica
Wallmann, Jürgen
Kietzmann, Manfred
Kaspar, Heike
author_facet Römer, Antje
Scherz, Gesine
Reupke, Saskia
Meißner, Jessica
Wallmann, Jürgen
Kietzmann, Manfred
Kaspar, Heike
author_sort Römer, Antje
collection PubMed
description BACKGROUND: In the European Union, various fluoroquinolones are authorised for the treatment of food producing animals. Each administration poses an increased risk of development and spread of antimicrobial resistance. The aim of this study was to investigate the impact of parenteral administration of enrofloxacin on the prevalence of enrofloxacin and ciprofloxacin susceptibilities in the commensal intestinal E. coli population. METHODS: E. coli isolates from faeces of twelve healthy pigs were included. Six pigs were administered enrofloxacin on day 1 to 3 and after two weeks for further three days. The other pigs formed the control group. MIC values were determined. Virulence and resistance genes were detected by PCR. Phylogenetic grouping was performed by PCR. Enrofloxacin and ciprofloxacin were analysed in sedimentation samples by HPLC. RESULTS: Susceptibility shifts in commensal E. coli isolates were determined in both groups. Non-wildtype E. coli could be cultivated from two animals of the experimental group for the first time one week after the first administration and from one animal of the control group on day 28. The environmental load with enrofloxacin in sedimentation samples showed the highest amount between days one and five. The repeated parenteral administration of enrofloxacin to pigs resulted in rapidly increased MIC values (day 28: MIC up to 4 mg/L, day 35: MIC ≥ 32mg/L). E. coli populations of the control group in the same stable without direct contact to the experimental group were affected. CONCLUSION: The parenteral administration of enrofloxacin to piglets considerably reduced the number of the susceptible intestinal E. coli population which was replaced by E. coli strains with increased MIC values against enrofloxacin. Subsequently also pigs of the control were affected suggesting a transferability of strains from the experimental group through the environment to the control group especially as we could isolate the same PFGE strains from both pig groups and the environment.
format Online
Article
Text
id pubmed-5715528
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-57155282017-12-08 Effects of intramuscularly administered enrofloxacin on the susceptibility of commensal intestinal Escherichia coli in pigs (sus scrofa domestica) Römer, Antje Scherz, Gesine Reupke, Saskia Meißner, Jessica Wallmann, Jürgen Kietzmann, Manfred Kaspar, Heike BMC Vet Res Research Article BACKGROUND: In the European Union, various fluoroquinolones are authorised for the treatment of food producing animals. Each administration poses an increased risk of development and spread of antimicrobial resistance. The aim of this study was to investigate the impact of parenteral administration of enrofloxacin on the prevalence of enrofloxacin and ciprofloxacin susceptibilities in the commensal intestinal E. coli population. METHODS: E. coli isolates from faeces of twelve healthy pigs were included. Six pigs were administered enrofloxacin on day 1 to 3 and after two weeks for further three days. The other pigs formed the control group. MIC values were determined. Virulence and resistance genes were detected by PCR. Phylogenetic grouping was performed by PCR. Enrofloxacin and ciprofloxacin were analysed in sedimentation samples by HPLC. RESULTS: Susceptibility shifts in commensal E. coli isolates were determined in both groups. Non-wildtype E. coli could be cultivated from two animals of the experimental group for the first time one week after the first administration and from one animal of the control group on day 28. The environmental load with enrofloxacin in sedimentation samples showed the highest amount between days one and five. The repeated parenteral administration of enrofloxacin to pigs resulted in rapidly increased MIC values (day 28: MIC up to 4 mg/L, day 35: MIC ≥ 32mg/L). E. coli populations of the control group in the same stable without direct contact to the experimental group were affected. CONCLUSION: The parenteral administration of enrofloxacin to piglets considerably reduced the number of the susceptible intestinal E. coli population which was replaced by E. coli strains with increased MIC values against enrofloxacin. Subsequently also pigs of the control were affected suggesting a transferability of strains from the experimental group through the environment to the control group especially as we could isolate the same PFGE strains from both pig groups and the environment. BioMed Central 2017-12-04 /pmc/articles/PMC5715528/ /pubmed/29202759 http://dx.doi.org/10.1186/s12917-017-1260-8 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Römer, Antje
Scherz, Gesine
Reupke, Saskia
Meißner, Jessica
Wallmann, Jürgen
Kietzmann, Manfred
Kaspar, Heike
Effects of intramuscularly administered enrofloxacin on the susceptibility of commensal intestinal Escherichia coli in pigs (sus scrofa domestica)
title Effects of intramuscularly administered enrofloxacin on the susceptibility of commensal intestinal Escherichia coli in pigs (sus scrofa domestica)
title_full Effects of intramuscularly administered enrofloxacin on the susceptibility of commensal intestinal Escherichia coli in pigs (sus scrofa domestica)
title_fullStr Effects of intramuscularly administered enrofloxacin on the susceptibility of commensal intestinal Escherichia coli in pigs (sus scrofa domestica)
title_full_unstemmed Effects of intramuscularly administered enrofloxacin on the susceptibility of commensal intestinal Escherichia coli in pigs (sus scrofa domestica)
title_short Effects of intramuscularly administered enrofloxacin on the susceptibility of commensal intestinal Escherichia coli in pigs (sus scrofa domestica)
title_sort effects of intramuscularly administered enrofloxacin on the susceptibility of commensal intestinal escherichia coli in pigs (sus scrofa domestica)
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5715528/
https://www.ncbi.nlm.nih.gov/pubmed/29202759
http://dx.doi.org/10.1186/s12917-017-1260-8
work_keys_str_mv AT romerantje effectsofintramuscularlyadministeredenrofloxacinonthesusceptibilityofcommensalintestinalescherichiacoliinpigssusscrofadomestica
AT scherzgesine effectsofintramuscularlyadministeredenrofloxacinonthesusceptibilityofcommensalintestinalescherichiacoliinpigssusscrofadomestica
AT reupkesaskia effectsofintramuscularlyadministeredenrofloxacinonthesusceptibilityofcommensalintestinalescherichiacoliinpigssusscrofadomestica
AT meißnerjessica effectsofintramuscularlyadministeredenrofloxacinonthesusceptibilityofcommensalintestinalescherichiacoliinpigssusscrofadomestica
AT wallmannjurgen effectsofintramuscularlyadministeredenrofloxacinonthesusceptibilityofcommensalintestinalescherichiacoliinpigssusscrofadomestica
AT kietzmannmanfred effectsofintramuscularlyadministeredenrofloxacinonthesusceptibilityofcommensalintestinalescherichiacoliinpigssusscrofadomestica
AT kasparheike effectsofintramuscularlyadministeredenrofloxacinonthesusceptibilityofcommensalintestinalescherichiacoliinpigssusscrofadomestica